Abstract
Bioinformatics applies unbiased approaches to develop statistically robust insight into health and disease. At the global, or “20,000 ft” view bioinformatic analyses of NR signaling can measure how the NRs are implicated in human health and disease through the impact of genome-wide significant genetic variation, family-wide NR expression patterns or considering where NRs are significantly identified in other high-dimensional data analyses. With a more NR-centric, or “2000 ft” view, bioinformatic approaches can interrogate events downstream of a given NR. Integrative approaches aim to combine multiple NR-centric high-dimensional data both derived in cell models and primary human tissue to reveal how NR-transcriptional networks relate to human health and disease. Bioinformatic approaches to such high-dimensional data are central and require specialist statistical insight and computational skills, coupled with a dexterous understanding of the biological question. A current challenge is determining the optimal mechanism to share such bioinformatic approaches through the biological research community.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fodor SP et al (1993) Multiplexed biochemical assays with biological chips. Nature 364(6437):555–556
Welford SM et al (1998) Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization. Nucleic Acids Res 26(12):3059–3065
Brazma A et al (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29(4):365–371
R Core Team (2018) R: a language and environment for statistical computing. R4, 2018. Foundation for Statistical Computing. https://www.R-project.org/
Gentleman RC et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10):R80
Gentalen E, Chee M (1999) A novel method for determining linkage between DNA sequences: hybridization to paired probe arrays. Nucleic Acids Res 27(6):1485–1491
Eads CA et al (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28(8):E32
Humphery-Smith I, Blackstock W (1997) Proteome analysis: genomics via the output rather than the input code. J Protein Chem 16(5):537–544
Tsugawa H (2018) Advances in computational metabolomics and databases deepen the understanding of metabolisms. Curr Opin Biotechnol 54:10–17
Orlando V, Paro R (1993) Mapping polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin. Cell 75(6):1187–1198
Mockler TC et al (2005) Applications of DNA tiling arrays for whole-genome analysis. Genomics 85(1):1–15
Robertson G et al (2007) Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 4(8):651–657
Paul J (1981) Sir George Beatson and the Royal Beatson Memorial Hospital. Med Hist 25(2):200–201
Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26(4):239–257
Gorski J, Gannon F (1976) Current models of steroid hormone action: a critique. Annu Rev Physiol 38:425–450
Yamamoto K, Alberts B (1975) The interaction of estradiol-receptor protein with the genome: an argument for the existence of undetected specific sites. Cell 4(4):301–310
Weinberger C et al (1985) Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 228(4700):740–742
Green S et al (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320(6058):134–139
Weinberger C et al (1986) The c-erb-A gene encodes a thyroid hormone receptor. Nature 324(6098):641–646
McDonnell DP et al (1987) Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235(4793):1214–1217
Petkovich M et al (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330(6147):444–450
Giguere V et al (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330(6149):624–629
Reichel RR, Jacob ST (1993) Control of gene expression by lipophilic hormones. FASEB J 7(5):427–436
Galon J et al (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16(1):61–71
Lyakhovich A et al (2000) Vitamin D induced up-regulation of keratinocyte growth factor (FGF-7/KGF) in MCF-7 human breast cancer cells. Biochem Biophys Res Commun 273(2):675–680
Rusiniak ME et al (2000) Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia. Cancer Res 60(7):1824–1829
Elek J, Park KH, Narayanan R (2000) Microarray-based expression profiling in prostate tumors. In Vivo 14(1):173–182
Yang GP et al (1999) Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes. Nucleic Acids Res 27(6):1517–1523
Chatterjee S et al (2016) Enhancer variants synergistically drive dysfunction of a gene regulatory network in Hirschsprung disease. Cell 167(2):355–368. e10
Eckel-Mahan KL et al (2013) Reprogramming of the circadian clock by nutritional challenge. Cell 155(7):1464–1478
Mikkelsen TS et al (2010) Comparative epigenomic analysis of murine and human adipogenesis. Cell 143(1):156–169
Maret S et al (2005) Retinoic acid signaling affects cortical synchrony during sleep. Science 310(5745):111–113
Cancer Genome Atlas Research Network (2015) The molecular taxonomy of primary prostate cancer. Cell 163(4):1011–1025
Ciriello G et al (2015) Comprehensive molecular portraits of invasive lobular breast cancer. Cell 163(2):506–519
Sudlow C et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779
Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061–1068
Cerami E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401–404
van Dijk EL, Jaszczyszyn Y, Thermes C (2014) Library preparation methods for next-generation sequencing: tone down the bias. Exp Cell Res 322(1):12–20
Ren X et al (2017) Gene set analysis controlling for length bias in RNA-seq experiments. BioData Min 10:5
Poirion OB et al (2016) Single-cell transcriptomics bioinformatics and computational challenges. Front Genet 7:163
Choi SH et al (2017) Evaluation of logistic regression models and effect of covariates for case-control study in RNA-Seq analysis. BMC Bioinformatics 18(1):91
Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550
Kumar D et al (2016) Integrating transcriptome and proteome profiling: strategies and applications. Proteomics 16(19):2533–2544
MacArthur J et al (2017) The new NHGRI-EBI catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res 45(D1):D896–D901
Welter D et al (2014) The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42(Database issue):D1001–D1006
McKay JD et al (2017) Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nat Genet 49(7):1126–1132
Kote-Jarai Z et al (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 43(8):785–791
Willer CJ et al (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45(11):1274–1283
Sabatti C et al (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41(1):35–46
Jostins L et al (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491(7422):119–124
Shungin D et al (2015) New genetic loci link adipose and insulin biology to body fat distribution. Nature 518(7538):187–196
Gelernter J et al (2014) Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene. Mol Psychiatry 19(6):717–723
Boyle AP et al (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 22(9):1790–1797
Djebali S et al (2012) Landscape of transcription in human cells. Nature 489(7414):101–108
Roadmap Epigenomics C et al (2015) Integrative analysis of 111 reference human epigenomes. Nature 518(7539):317–330
Gallone G et al (2017) Identification of genetic variants affecting vitamin D receptor binding and associations with autoimmune disease. Hum Mol Genet 26(11):2164–2176
Singh PK et al (2017) Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-kappaB binding that is linked to immune phenotypes. BMC Genomics 18(1):132
Long MD et al (2015) Integrative genomic analysis in K562 chronic myelogenous leukemia cells reveals that proximal NCOR1 binding positively regulates genes that govern erythroid differentiation and Imatinib sensitivity. Nucleic Acids Res 43(15):7330–7348
Long MD et al (2018) The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression. Oncogene. 2018 Aug 17. https://doi.org/10.1038/s41388-018-0450-6. [Epub ahead of print] PubMed PMID: 30120411
Gao J et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1
Taylor BS et al (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11–22
Long MD, Campbell MJ (2015) Pan-cancer analyses of the nuclear receptor superfamily. Nucl Receptor Res 2:pii: 101182
Long MD et al (2014) Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer. Carcinogenesis 35(2):262–271
Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507(7492):315–322
Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490(7418):61–70
Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330–337
Cancer Genome Atlas Network (2015) Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517(7536):576–582
Ahn SM et al (2014) Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification. Hepatology 60(6):1972–1982
Long MD, Campbell MJ (2017) Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer. J Steroid Biochem Mol Biol 173:130–138
Satelli A et al (2011) Galectin-4 functions as a tumor suppressor of human colorectal cancer. Int J Cancer 129(4):799–809
Belo AI et al (2013) Galectin-4 reduces migration and metastasis formation of pancreatic cancer cells. PLoS One 8(6):e65957
Kim SW et al (2013) Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer. Cell Oncol (Dordr) 36(2):169–178
Tsai CH et al (2016) Metastatic progression of prostate cancer is mediated by autonomous binding of galectin-4-O-glycan to cancer cells. Cancer Res 76(19):5756–5767
Palmer HG et al (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 10(9):917–919
Pena C et al (2005) E-Cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 14(22):3361–3370
Pereira F et al (2011) KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet 20(23):4655–4665
Larriba MJ et al (2011) Vitamin D receptor deficiency enhances Wnt/beta-catenin signaling and tumor burden in colon cancer. PLoS One 6(8):e23524
Wang W et al (2011) Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc Natl Acad Sci U S A 108(45):18283–18288
Simandi Z et al (2016) OCT4 acts as an integrator of pluripotency and signal-induced differentiation. Mol Cell 63(4):647–661
Bryant SL et al (2014) Sex specific retinoic acid signaling is required for the initiation of urogenital sinus bud development. Dev Biol 395(2):209–217
Lohnes D et al (1993) Function of retinoic acid receptor gamma in the mouse. Cell 73(4):643–658
Vezina CM et al (2008) Retinoic acid induces prostatic bud formation. Dev Dyn 237(5):1321–1333
Mariotti A et al (1987) Actions and interactions of estradiol and retinoic acid in mouse anterior prostate gland. Biol Reprod 37(4):1023–1035
Mele M et al (2015) Human genomics. The human transcriptome across tissues and individuals. Science 348(6235):660–665
Ecker JR et al (2017) The BRAIN initiative cell census consortium: lessons learned toward generating a comprehensive brain cell atlas. Neuron 96(3):542–557
Palmer HG et al (2003) Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 63(22):7799–7806
Koike M et al (1997) 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines. Cancer Res 57(20):4545–4550
Campbell MJ et al (1997) Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol 19(1):15–27
Elstner E et al (1999) Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate 40(3):141–149
Peehl DM et al (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54(3):805–810
Welsh J et al (2002) Impact of the vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 83(1–5):85–92
Colston KW, Berger U, Coombes RC (1989) Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1(8631):188–191
Colston K et al (1982) 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res 42(3):856–859
Savli H et al (2002) Gene expression analysis of 1,25(OH)2D3-dependent differentiation of HL-60 cells: a cDNA array study. Br J Haematol 118(4):1065–1070
Akutsu N et al (2001) Regulation of gene expression by 1alpha,25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells. Mol Endocrinol 15(7):1127–1139
Eelen G et al (2004) Microarray analysis of 1alpha,25-dihydroxyvitamin D3-treated MC3T3-E1 cells. J Steroid Biochem Mol Biol 89–90(1–5):405–407
Wang TT et al (2005) Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19(11):2685–2695
Lin R et al (2002) Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol 16(6):1243–1256
Ding N et al (2013) A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153(3):601–613
Heikkinen S et al (2011) Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res 39(21):9181–9193
Meyer MB, Goetsch PD, Pike JW (2012) VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol Endocrinol 26(1):37–51
Ramagopalan SV et al (2010) A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 20(10):1352–1360
Tuoresmaki P et al (2014) Patterns of genome-wide VDR locations. PLoS One 9(4):e96105
Raney BJ et al (2011) ENCODE whole-genome data in the UCSC genome browser (2011 update). Nucleic Acids Res 39(Database issue):D871–D875
Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30(7):923–930
Lun AT, Smyth GK (2016) csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows. Nucleic Acids Res 44(5):e45
Zhang Y et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9(9):R137
Mei S et al (2017) Cistrome data browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse. Nucleic Acids Res 45(D1):D658–D662
Hua S, Kittler R, White KP (2009) Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137(7):1259–1271
Yang F et al (2017) Glucocorticoid receptor: MegaTrans switching mediates the repression of an ERalpha-regulated transcriptional program. Mol Cell 66(3):321–331. e6
Liu Z et al (2014) Enhancer activation requires trans-recruitment of a mega transcription factor complex. Cell 159(2):358–373
Grebbin BM, Schulte D (2017) PBX1 as pioneer factor: a case still open. Front Cell Dev Biol 5:9
Golson ML, Kaestner KH (2016) Fox transcription factors: from development to disease. Development 143(24):4558–4570
Goldstein I, Hager GL (2018) Dynamic enhancer function in the chromatin context. Wiley Interdiscip Rev Syst Biol Med:10(1). https://doi.org/10.1002/wsbm.1390
Hager GL, McNally JG, Misteli T (2009) Transcription dynamics. Mol Cell 35(6):741–753
Biddie SC, Hager GL (2009) Glucocorticoid receptor dynamics and gene regulation. Stress 12(3):193–205
Mohammed H et al (2016) Rapid immunoprecipitation mass spectrometry of endogenous proteins (RIME) for analysis of chromatin complexes. Nat Protoc 11(2):316–326
Ernst J, Kellis M (2017) Chromatin-state discovery and genome annotation with ChromHMM. Nat Protoc 12(12):2478–2492
Ernst J, Kellis M (2012) ChromHMM: automating chromatin-state discovery and characterization. Nat Methods 9(3):215–216
Shaffer PL, Gewirth DT (2004) Structural analysis of RXR-VDR interactions on DR3 DNA. J Steroid Biochem Mol Biol 89-90(1–5):215–219
Sasaki H et al (1995) Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression. Biochemistry 34(1):370–377
Carlberg C, Campbell MJ (2013) Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 78(2):127–136
Birney E (2012) The making of ENCODE: lessons for big-data projects. Nature 489(7414):49–51
Sanli K et al (2013) FANTOM: functional and taxonomic analysis of metagenomes. BMC Bioinformatics 14:38
Buenrostro JD et al (2015) ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr Protoc Mol Biol 109:21.291–21.299
Jeselsohn R et al (2018) Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations. Cancer Cell 33(2):173–186. e5
Tarallo R et al (2017) The nuclear receptor ERbeta engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading. Genome Biol 18(1):189
Hamed M et al (2017) Insights into interplay between rexinoid signaling and myogenic regulatory factor-associated chromatin state in myogenic differentiation. Nucleic Acids Res 45(19):11236–11248
Armour SM et al (2017) An HDAC3-PROX1 corepressor module acts on HNF4alpha to control hepatic triglycerides. Nat Commun 8(1):549
Zhang Y et al (2017) The hepatic circadian clock fine-tunes the lipogenic response to feeding through RORalpha/gamma. Genes Dev 31(12):1202–1211
Dreijerink KMA et al (2017) Enhancer-mediated oncogenic function of the menin tumor suppressor in breast cancer. Cell Rep 18(10):2359–2372
Malinen M et al (2017) Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-kappaB cistrome to reprogram the prostate cancer cell transcriptome. Nucleic Acids Res 45(2):619–630
Savic D et al (2016) Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation. Genome Med 8(1):74
Taberlay PC et al (2016) Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations. Genome Res 26(6):719–731
Fiorito E et al (2016) CTCF modulates estrogen receptor function through specific chromatin and nuclear matrix interactions. Nucleic Acids Res 44(22):10588–10602
Mourad R et al (2014) Estrogen induces global reorganization of chromatin structure in human breast cancer cells. PLoS One 9(12):e113354
Wang J et al (2013) Genome-wide analysis uncovers high frequency, strong differential chromosomal interactions and their associated epigenetic patterns in E2-mediated gene regulation. BMC Genomics 14:70
Kim YH et al (2018) Rev-erbalpha dynamically modulates chromatin looping to control circadian gene transcription. Science 359(6381):1274–1277
Neme A, Seuter S, Carlberg C (2016) Vitamin D-dependent chromatin association of CTCF in human monocytes. Biochim Biophys Acta 1859(11):1380–1388
Mifsud B et al (2017) GOTHiC, a probabilistic model to resolve complex biases and to identify real interactions in Hi-C data. PLoS One 12(4):e0174744
Lun AT, Perry M, Ing-Simmons E (2016) Infrastructure for genomic interactions: Bioconductor classes for Hi-C, ChIA-PET and related experiments. F1000Res 5:950
Harmston N et al (2015) GenomicInteractions: An R/Bioconductor package for manipulating and investigating chromatin interaction data. BMC Genomics 16:963
Lun AT, Smyth GK (2015) diffHic: a bioconductor package to detect differential genomic interactions in Hi-C data. BMC Bioinformatics 16:258
Dayhoff MO (1969) Computer analysis of protein evolution. Sci Am 221(1):86–95
Dayhoff MO (1965) Computer aids to protein sequence determination. J Theor Biol 8(1):97–112
Hogeweg P (2011) The roots of bioinformatics in theoretical biology. PLoS Comput Biol 7(3):e1002021
Roberts L et al (2001) A history of the Human Genome Project. Science 291(5507):1195
Consortium EP et al (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447(7146):799–816
Bujold D et al (2016) The international human epigenome consortium data portal. Cell Syst 3(5):496–499. e2
Chen L et al (2016) Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell 167(5):1398–1414. e24
Cancer Genome Atlas Research Network et al (2013) The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet 45(10):1113–1120
Weaver W (1970) Molecular biology: origin of the term. Science 170(3958):581–582
Danna K, Nathans D (1971) Specific cleavage of simian virus 40 DNA by restriction endonuclease of Hemophilus influenzae. Proc Natl Acad Sci U S A 68(12):2913–2917
Saiki RK et al (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239(4839):487–491
Hunkapiller T et al (1991) Large-scale and automated DNA sequence determination. Science 254(5028):59–67
Tavera-Mendoza LE et al (2008) Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist. Proc Natl Acad Sci U S A 105(24):8250–8255
Acknowledgments
M.J.C. acknowledges support in part from the Prostate program of the Department of Defense Congressionally Directed Medical Research Programs [W81XWH-14-1-0608].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Campbell, M.J. (2019). High-Dimensional Data Approaches to Understanding Nuclear Hormone Receptor Signaling. In: Badr, M. (eds) Nuclear Receptors. Methods in Molecular Biology, vol 1966. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9195-2_23
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9195-2_23
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9194-5
Online ISBN: 978-1-4939-9195-2
eBook Packages: Springer Protocols